Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with transthyretin cardiac amyloidosis (a condition where a protein called transthyretin builds up in the heart), with or without reduced heart function
- People who are willing to follow the study's procedures and requirements
- People who are able to read, understand, and sign a consent form agreeing to take part
Who may not be able to join:
- People who have other serious heart conditions, such as severely blocked heart arteries or major problems with the heart's valves, that could affect the study results
- People who are unable to sign a consent form or who are unable to take part in the required medical check-ups and assessments during the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +551126615057
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Serum concentration of circulating extracellular vesicles (EVs); Circulating extracellular vesicle protein profile
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.